This dual action helps rebuild and maintain the skin's underlying support structure, gradually smoothing existing wrinkles and preventing the formation of new ones
That said, it is important to understand that these are not benign creams they are medications that affect immune and hormonal pathways in the skin (and, in rare cases, the body)
At a concentration of 10 mM, exposure was found to cause profound intracellular Ca 2+ overload and significant Ca 2+ -dependent lytic cell death
An increase in resting heart rate has been reported in some patients

Absolute Contraindications BPC-157 is not recommended for patients with: Active cancer (any type) theoretical concern regarding angiogenesis promotion Pregnancy or breastfeeding insufficient safety data Known hypersensitivity to any component of the formulation Relative Contraindications (Require Individualized Assessment) History of cancer after completion of treatment, a waiting period and oncology clearance may be appropriate Autoimmune disease especially if active or requiring immunosuppressive therapy Anticoagulant use injection site bleeding risk, though minimal with proper technique Severe renal or hepatic impairment dosing adjustments may be needed Monitoring and Follow-Up Patients on BPC-157 protocols are monitored through: Baseline and follow-up labs including inflammatory markers (CRP, ESR), complete blood count, and metabolic panel Clinical assessments pain scores, range of motion, functional outcomes at 2-week, 4-week, and 8-week intervals Imaging when indicated repeat ultrasound or MRI for musculoskeletal conditions to document structural healing The Patient Journey: What to Expect For patients considering peptide therapy, understanding the timeline of response helps set realistic expectations
